Detalhe da pesquisa
1.
Quality standards for the care of people with giant cell arteritis in secondary care.
Rheumatology (Oxford)
; 62(9): 3075-3083, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692142
2.
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).
Rheumatology (Oxford)
; 62(9): 3133-3138, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36637209
3.
The BILAG-2004 index is associated with development of new damage in SLE.
Rheumatology (Oxford)
; 62(2): 668-675, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686924
4.
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England.
Rheumatology (Oxford)
; 2023 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952183
5.
BSR guideline on the management of adults with systemic lupus erythematosus (SLE) 2018: baseline multi-centre audit in the UK.
Rheumatology (Oxford)
; 60(3): 1480-1490, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33291150
6.
Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE-data from the BSR audit of systemic lupus erythematosus.
Rheumatology (Oxford)
; 60(3): 1474-1479, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677595
7.
A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA.
Hum Mol Genet
; 26(13): 2565-2576, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28379387
8.
COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes.
Rheumatology (Oxford)
; 62(6): e185-e187, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534829
9.
Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activity.
Rheumatology (Oxford)
; 57(5): 921-930, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29474655
10.
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.
Rheumatology (Oxford)
; 57(3): 470-479, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29216396
11.
Physical activity but not sedentary activity is reduced in primary Sjögren's syndrome.
Rheumatol Int
; 37(4): 623-631, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28013357
12.
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.
Rheumatology (Oxford)
; 55(3): 544-52, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26510429
13.
What do UK Rheumatologists do when the patient doesn't fit the guideline for treatment?
Rheumatology (Oxford)
; 59(7): 1465-1466, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294218
14.
Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis.
Rheumatology (Oxford)
; 54(11): 2015-24, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26116156
15.
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids.
Rheumatology (Oxford)
; 54(6): 1050-5, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25433040
16.
Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?
Rheumatology (Oxford)
; 54(4): 655-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25240612
17.
Health-related utility values of patients with primary Sjögren's syndrome and its predictors.
Ann Rheum Dis
; 73(7): 1362-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23761688
18.
Novel photoplethysmography cardiovascular assessments in patients with Raynaud's phenomenon and systemic sclerosis: a pilot study.
Rheumatology (Oxford)
; 53(10): 1855-63, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24850874
19.
Giant cell arteritis: new concepts, treatments and the unmet need that remains.
Rheumatology (Oxford)
; 58(7): 1123-1125, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423174
20.
Giant cell arteritis: new concepts, treatments and the unmet need that remains.
Rheumatology (Oxford)
; 58(7): 1316, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30544209